上海复星医药(集团)股份有限公司
Shanghai Fosun Pharmaceutical Group Co LtdCNCNYShanghai Fosun Pharmaceutical Group Co Ltd (HK:2196) — Drug Manufacturers - Specialty & Generic. Numero di borse in cui sono quotate le azioni della società: 3. In questa pagina: prezzo e grafico, dividendi, principali azionisti e cronologia del numero di azioni.
Informazioni sull'Azienda
- Sito Web
- fosunpharma.com
- Settore
- Healthcare · Drug Manufacturers - Specialty & Generic
- Sede Centrale
- Shanghai, China
- Amministratore Delegato
- Yi Liu
- Dipendenti
- 40 684
- Fondata
- 1994
- Quotata dal
- 30.10.2012 (HK:2196)
- Azioni in Circolazione
- Flottante
- 1.63 Mld
- Capitalizzazione di Mercato
- 9.27 Mld HKD
- Insider
- 43.02%
- Investitori Istituzionali
- 8.48%
- ISIN
- CNE100001M79
- Payout Ratio
- 54.2%
- FCF
- 885 Mln CNY
- Payout / FCF
- 213%
- Debito
- 39.5 Mld CNY18 anni di FCF
- Serie di Dividendi
- 25 a.
- Utili, FCF e dividendi pagati — per i 12 mesi fino a 31.03.2026 (l'ultimo rapporto dell'azienda).
Descrizione
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Dividendi
Shanghai Fosun Pharmaceutical Group Co Ltd (2196) paga dividendi una volta all'anno. All'anno (12 mesi fino all'ultimo pagamento annunciato): 0.45 HKD per azione (pagamenti: 1). Questo rappresenta circa il 2.57% del prezzo attuale delle azioni. In base alla storia dei pagamenti, la prossima data ex-dividendo è prevista intorno al 14.07.2027. Storia dei dividendi ininterrotta: 25 anni.
| Data Ex | Pagamento | Importo | % | Tipo | Ticker |
|---|---|---|---|---|---|
| 2026-07-16 | — | 0.4500 HKD | 2.6/2.6 % | annuale | HK:2196 |
| 2025-07-24 | — | 0.3500 HKD | 1.9/1.9 % | annuale | HK:2196 |
| 2024-07-26 | — | 0.3000 HKD | 2.3/2.3 % | annuale | HK:2196 |
| 2023-07-31 | — | 0.4600 HKD | 2.2/2.2 % | annuale | HK:2196 |
| 2022-06-08 | — | 0.6600 HKD | 2.0/2.0 % | annuale | HK:2196 |
Principali Azionisti
| Detentore | Quota | Azioni | Data del Rapporto |
|---|---|---|---|
| Wu (Yi Fang) (Director) | ≈0.04% | 1.06 Mln | 2018-12-31 |
